An inhibitor of C3 activation, Crry, targeted to ischemic neurons, prevented phagocytosis of stressed-but-salvageable neurons and synapses in the ischemic penumbra, and improved cognitive function in mouse models of stroke [61,62]. This evidence concerns the gene C3 and Stroke.